Literature DB >> 8965784

Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association.

.   

Abstract

This report concerning the immunization of adolescents (i.e., persons 11-21 years of age, as defined by the American Medical Association [AMA] and the American Academy of Pediatrics [AAP]) is a supplement to previous publications (i.e., MMWR 1994;43[No. RR-1]1-38; the AAP 1994 Red Book: Report of the Committee on Infectious Diseases; Summary of Policy Recommendations for Periodic Health Examination, August 1996 from the American Academy of Family Physicians [AAFP]; and AMA Guidelines for Adolescent Preventive Services [GAPS]: Recommendations and Rationale). This report presents a new strategy to improve the delivery of vaccination services to adolescents and to integrate recommendations for vaccination with other preventive services provided to adolescents. This new strategy emphasizes vaccination of adolescents 11-12 years of age by establishing a routine visit to their health-care providers. Specifically, the purposes of this visit are to a) vaccinate adolescents who have not been previously vaccinated with varicella virus vaccine, hepatitis B vaccine, or the second dose of the measles, mumps, and rubella (MMR) vaccine; b) provide a booster dose of tetanus and diphtheria toxoids; c) administer other vaccines that may be recommended for certain adolescents; and d) provide other recommended preventive services. The recommendations for vaccination of adolescents are based on new or current information for each vaccine. The most recent recommendations from ACIP, AAP, AAFP, and AMA concerning specific vaccines and delivery of preventive services should be consulted for details (Exhibit 2).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8965784

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  19 in total

1.  A middle school immunization law rapidly and substantially increases immunization coverage among adolescents.

Authors:  Francisco Averhoff; Leslie Linton; K Michael Peddecord; Christine Edwards; Wendy Wang; Daniel Fishbein
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

2.  Clinical benefits of routine varicella vaccination for adults.

Authors:  Cinzia Germinario; Maria Serena Gallone; Maria Giovanna Cappelli; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Substance abuse and high-risk needle-related behaviors among homeless youth in Minneapolis: implications for prevention.

Authors:  A R Lifson; L L Halcón
Journal:  J Urban Health       Date:  2001-12       Impact factor: 3.671

4.  Minor consent and delivery of adolescent vaccines.

Authors:  Carol A Ford; Martha P Skiles; Abigail English; Jianwen Cai; Robert P Agans; Shannon Stokley; Lauri Markowitz; Emilia H Koumans
Journal:  J Adolesc Health       Date:  2013-09-25       Impact factor: 5.012

5.  The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004.

Authors:  Ellen T Chang; Theresa H M Keegan; Scarlett L Gomez; Gem M Le; Christina A Clarke; Samuel K S So; Sally L Glaser
Journal:  Cancer       Date:  2007-05-15       Impact factor: 6.860

Review 6.  Active immunization in the United States: developments over the past decade.

Authors:  P H Dennehy
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Association of Provider Recommendation and Human Papillomavirus Vaccination Initiation among Male Adolescents Aged 13-17 Years-United States.

Authors:  Peng-Jun Lu; David Yankey; Benjamin Fredua; Alissa C O'Halloran; Charnetta Williams; Lauri E Markowitz; Laurie D Elam-Evans
Journal:  J Pediatr       Date:  2018-11-15       Impact factor: 4.406

8.  Concomitant Adolescent Vaccination in the U.S., 2007-2012.

Authors:  Jennifer L Moss; Paul L Reiter; Noel T Brewer
Journal:  Am J Prev Med       Date:  2016-06-30       Impact factor: 5.043

9.  Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: demand, supply and seasonality.

Authors:  Suchita A Lorick; Daniel Fishbein; Eric Weintraub; Pascale M Wortley; Grace M Lee; Fangjun Zhou; Robert Davis
Journal:  BMC Infect Dis       Date:  2009-11-03       Impact factor: 3.090

10.  Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study.

Authors:  Lisa A Jackson; Onchee Yu; Edward A Belongia; Simon J Hambidge; Jennifer Nelson; Roger Baxter; Allison Naleway; Charlene Gay; James Nordin; James Baggs; John Iskander
Journal:  BMC Infect Dis       Date:  2009-10-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.